Diethylaniline

Diethylaniline

SCHEMBL77147

Bc1cccc2ccc3cc4ccccc4cc3c12.CCN(CC)c1ccccc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.38
TSHR P16473 1/20 0.38
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
ALDH1A1 P00352 3/20 0.37
TERT O14746 1/20 0.37
CYP3A4 P08684 1/20 0.37
KDM1A O60341 1/20 0.35
NPC1 O15118 3/20 0.35
ACHE P22303 2/20 0.35
ERBB2 P04626 1/20 0.35
CYP1A2 P05177 1/20 0.35
FYN P06241 1/20 0.35
MAOA P21397 1/20 0.35
AHR P35869 1/20 0.35
APAF1 O14727 1/20 0.35
CASP3 P42574 1/20 0.35
CASP6 P55212 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL88316 0.85 CYP1A2 (0.39) TSHRALDH1A1ACHEERBB2CYP1A2
SCHEMBL887067 0.84 CYP1A2 (0.38) TSHRMEN1KMT2AALDH1A1TERT
Diethylaniline SCHEMBL297014 0.83 CNR2 (0.38) CNR2TSHRMEN1KMT2AALDH1A1
Ethylamine SCHEMBL728739 0.82 CYP1A2 (0.41) TSHRMEN1KMT2AALDH1A1CYP3A4
Trimethylammonium SCHEMBL87962 0.82 CYP1A2 (0.43) TSHRMEN1KMT2AALDH1A1CYP3A4
SCHEMBL188027 0.82 CYP1A2 (0.48) TSHRMEN1KMT2AALDH1A1CYP3A4
SCHEMBL88441 0.80 BCHE (0.38) TSHRALDH1A1ACHEERBB2CYP1A2
SCHEMBL1109655 0.80 CYP1A2 (0.47) TSHRMEN1KMT2AALDH1A1CYP3A4
SCHEMBL3175611 0.80 CYP1A2 (0.47) TSHRMEN1KMT2AALDH1A1CYP3A4
SCHEMBL10611693 0.80 CYP1A2 (0.47) TSHRMEN1KMT2AALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 451 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240101728-A1 HYBRID CATALYST COMPOSITION, CATALYST COMPRISING SAME, AND METHOD FOR PREPARING OLEFIN-BASED POLYMER USING SAME Hanwha Solutions Corporation (KR) 2024-03-28 US claimed
US-20240010760-A1 TRANSITION METAL COMPOUND, CATALYST COMPRISING SAME, AND METHOD FOR PREPARING SAME Hanwha Solutions Corporation (KR) 2024-01-11 US claimed
EP-4269453-A1 HYBRID CATALYST COMPOSITION, CATALYST COMPRISING SAME, AND METHOD FOR PREPARING OLEFIN-BASED POLYMER USING SAME Hanwha Solutions Corporation (KR) 2023-11-01 EP claimed
EP-4253393-A1 TRANSITION METAL COMPOUND, CATALYST COMPRISING SAME, AND METHOD FOR PREPARING SAME Hanwha Solutions Corporation (KR) 2023-10-04 EP claimed
WO-2023106779-A1 CATALYST FOR OLEFIN POLYMERIZATION COMPRISING HYBRID CATALYST COMPOSITION AND OLEFINIC POLYMER PREPARED USING SAME 한화솔루션 주식회사 2023-06-15 WO claimed
WO-2023096297-A1 POLYOLEFIN HAVING EXCELLENT PROCESSABILITY AND PROCESS FOR PREPARING SAME 한화솔루션 주식회사 2023-06-01 WO claimed
EP-3321291-B1 CATALYST COMPOSITION COMPRISING NOVEL TRANSITION METAL COMPOUND LG CHEMICAL LTD (KR) 2022-05-18 EP claimed
WO-2021241927-A1 MIXED CATALYTIC COMPOSITION, CATALYST COMPRISING SAME, AND METHODS FOR PREPARING SAME 한화솔루션 주식회사 2021-12-02 WO claimed
WO-2021112489-A1 METHOD FOR PRODUCING OLEFIN-BASED POLYMER 한화솔루션 주식회사 2021-06-10 WO claimed
US-10947327-B2 Catalyst composition including novel transition metal compound LG CHEM, LTD. 2021-03-16 US claimed
WO-2020130452-A1 CATALYST FOR OLEFIN POLYMERIZATION, AND OLEFIN-BASED POLYMER PRODUCED USING SAME 한화솔루션 주식회사 2020-06-25 WO claimed
WO-2020122500-A1 METHOD FOR PREPARING OLEFIN POLYMERIZATION CATALYST 한화솔루션 주식회사 2020-06-18 WO claimed
WO-2020116842-A1 METHOD FOR PREPARING CATALYST FOR OLEFIN POLYMERIZATION 한화솔루션 주식회사 2020-06-11 WO claimed
US-20180201697-A1 CATALYST COMPOSITION INCLUDING NOVEL TRANSITION METAL COMPOUND LG CHEM, LTD. (KR) 2018-07-19 US claimed
EP-3321291-A1 CATALYST COMPOSITION COMPRISING NOVEL TRANSITION METAL COMPOUND LG Chem, Ltd. (KR) 2018-05-16 EP claimed
EP-1517928-B1 SUPPORTED HYBRID METALLOCENE CATALYST, METHOD FOR PREPARING THE SAME, AND METHOD FOR PREPARING POLYOLEFIN USING THE SAME LG CHEMICAL LTD (KR) 2010-11-10 EP claimed
US-7294600-B2 Supported hybrid metallocene catalyst, method for preparing the same, and method for preparing polyolefin using the same LG CHEM, LTD. (KR) 2007-11-13 US claimed
EP-1844082-A1 MIXED SUPPORTED METALLOCENE CATALYST, METHOD OF PREPARING THE SAME, METHOD OF PREPARING POLYOLEFIN USING THE MIXED SUPPORTED METALLOCENE CATALYST, AND POLYOLEFIN PREPARED USING THE METHOD OF PREPARING POLYOLEFIN USING THE MIXED SUPPORTED METALLOCENE CATALYST LG Chem, Ltd. (KR) 2007-10-17 EP claimed
US-20060235171-A1 Supported hybrid metallocene catalyst, method for preparing the same, and method for preparing polyolefin using the same LG CHEM, LTD. (KR) 2006-10-19 US claimed
WO-2006080817-A1 MIXED SUPPORTED METALLOCENE CATALYST, METHOD OF PREPARING THE SAME, METHOD OF PREPARING POLYOLEFIN USING THE MIXED SUPPORTED METALLOCENE CATALYST, AND POLYOLEFIN PREPARED USING THE METHOD OF PREPARING POLYOLEFIN USING THE MIXED SUPPORTED METALLOCENE CATALYST LG CHEM, LTD. (KR) 2006-08-03 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10947327-B2 Catalyst composition including novel transition metal compound COG4, MCM4, ZNF436-AS1 CNR2 3428/4885TSHR 4773/4885MEN1 980/4885
US-20180201697-A1 CATALYST COMPOSITION INCLUDING NOVEL TRANSITION METAL COMPOUND COG4, MCM4, ZNF436-AS1 CNR2 3428/4885TSHR 4773/4885MEN1 980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.